An antibody of TNF alpha did not prevent thioacetamide induced hepatotoxicity in rats
dc.authorid | 101949 | en_US |
dc.contributor.author | Demirel, Ulvi | |
dc.contributor.author | Harputoğlu, Muhsin Murat Muhip | |
dc.contributor.author | Seçkin, Yüksel | |
dc.contributor.author | Çıralık, Harun | |
dc.contributor.author | Temel, İsmail | |
dc.contributor.author | Özyalın, Fatma | |
dc.contributor.author | Otlu, Barış | |
dc.contributor.author | Yılmaz, Bilgiç | |
dc.contributor.author | Dinçtürk, Mehmet Sarp | |
dc.contributor.author | Aladağ, Hülya | |
dc.date.accessioned | 2017-07-15T07:23:43Z | |
dc.date.available | 2017-07-15T07:23:43Z | |
dc.date.issued | 2011 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | Tumor necrosis factor (TNF)-a antibodies have been shown to reduce liver damage in different models. We investigated the effects of infliximab (a TNF-a antibody) on liver damage in thioacetamide (TAA)-induced hepatotoxicity in rats. Group 1 (n ¼ 8) was the control group. In group 2 (n ¼ 8), the TAA group, the rats received 300 mg/kg intraperitoneal (ip) TAA daily for 2 days. In group 3 (n ¼ 8), the TAA þ Infliximab (INF) group, infliximab (5 mg/kg ip daily) was administered 48 hours before the first dose of TAA daily for 2 days and was maintained for 4 consecutive days. In group 4 (n ¼ 8), the INF group, the rats received only ip infliximab (5 mg/kg) daily. Livers were excised for histopathological and biochemical tests (thiobarbituric-acid-reactive substances [TBARS], and myeloperoxidase [MPO]). Serum ammonia, aspartate transaminase (AST), alanine transaminase (ALT), TNF-a, liver TBARS and MPO levels, and liver necrosis and inflammation scores in the TAA group were significantly higher than in the control and INF groups (all p < 0.01). All parameters except AST were not significantly different between TAA and TAA þ INF. In conclusion, our results suggest that oxidative stress plays an important role in TAA-induced hepatotoxicity, and infliximab does not improve oxidative liver damage. | en_US |
dc.identifier.citation | Demirel, U. Harputoğlu, M. M. M. Seçkin, Y. Çıralık, H. Temel, İ. Özyalın, F. Otlu, B. Yılmaz, B. Dinçtürk, M. S. Aladağ, H. (2011). An antibody of TNF alpha did not prevent thioacetamide induced hepatotoxicity in rats. Human & experimental toxicology. 30(7) 560–566. | en_US |
dc.identifier.endpage | 566 | en_US |
dc.identifier.issn | 0960-3271 | |
dc.identifier.issue | 7 | en_US |
dc.identifier.startpage | 560 | en_US |
dc.identifier.uri | https://hdl.handle.net/11616/7382 | |
dc.identifier.volume | 30 | en_US |
dc.language.iso | en | en_US |
dc.publisher | Human&experimental toxicology | en_US |
dc.relation.ispartof | Human&experimental toxicology | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Infliximab | en_US |
dc.subject | Tumor necrosis factor-a | en_US |
dc.subject | Thioacetamide | en_US |
dc.subject | Oxidative stress | en_US |
dc.subject | Liver | en_US |
dc.title | An antibody of TNF alpha did not prevent thioacetamide induced hepatotoxicity in rats | en_US |
dc.type | Article | en_US |